Skip to main content
Top
Published in: BMC Geriatrics 1/2021

Open Access 01-12-2021 | Care | Research

Systematic geriatric assessment for older patients with frailty in the emergency department: a randomised controlled trial

Authors: Janne Alakare, Kirsi Kemp, Timo Strandberg, Maaret Castrén, Dimitrije Jakovljević, Jukka Tolonen, Veli-Pekka Harjola

Published in: BMC Geriatrics | Issue 1/2021

Login to get access

Abstract

Background

Comprehensive geriatric assessment provided in hospital wards in frail patients admitted to hospital has been shown to reduce mortality and increase the likelihood of living at home later. Systematic geriatric assessment provided in emergency departments (ED) may be effective for reducing days in hospital and unnecessary hospital admissions, but this has not yet been proven in randomised trials.

Methods

We conducted a single-centre, randomised controlled trial with a parallel-group, superiority design in an academic hospital ED.
ED patients aged ≥ 75 years who were frail, or at risk of frailty, as defined by the Clinical Frailty Scale, were included in the trial. Patients were recruited during the period between December 11, 2018 and June 7, 2019, and followed up for 365 days.
For the intervention group, systematic geriatric assessment was added to their standard care in the ED, whereas the control group received standard care only.
The primary outcome was cumulative hospital stay during 365-day follow-up. The secondary outcomes included: admission rate from the index visit, total hospital admissions, ED-readmissions, proportion of patients living at home at 365 days, 365-day mortality, and fall-related ED-visits.

Results

A total of 432 patients, 63 % female, with median age of 85 years, formed the analytic sample of 213 patients in the intervention group and 219 patients in the control group.
Cumulative hospital stay during one-year follow-up as rate per 100 person-years for the intervention and control groups were: 3470 and 3149 days, respectively, with rate ratio of 1.10 (95 % confidence interval, 0.55–2.19, P = .78). Admission rates to hospital wards from the index ED visit for the intervention and control groups were: 62 and 70 %, respectively (P = .10). No significant differences were observed between the groups for any outcomes.

Conclusion

Systematic geriatric assessment for older adults with frailty in the ED did not reduce hospital stay during one-year follow-up. No statistically significant difference was observed for any secondary outcomes. More coordinated, continuous interventions should be tested for potential benefits in long-term outcomes.

Trial registration

The trial was registered in the ClinicalTrials.gov (registration number and date NCT03751319 23/11/2018).
Literature
12.
go back to reference Ellis G, Jamieson CA, Alcorn M, Devlin V. An Acute Care for Elders (ACE) unit in the emergency department. Eur Geriatr Med. 2012;3(4):261–3.CrossRef Ellis G, Jamieson CA, Alcorn M, Devlin V. An Acute Care for Elders (ACE) unit in the emergency department. Eur Geriatr Med. 2012;3(4):261–3.CrossRef
Metadata
Title
Systematic geriatric assessment for older patients with frailty in the emergency department: a randomised controlled trial
Authors
Janne Alakare
Kirsi Kemp
Timo Strandberg
Maaret Castrén
Dimitrije Jakovljević
Jukka Tolonen
Veli-Pekka Harjola
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2021
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-021-02351-2

Other articles of this Issue 1/2021

BMC Geriatrics 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.